Research study Program year 2022 Source: CMS Open Payments

A Phase 2,Open-Label, Single-Arm Study to Evaluate the Efficacy and SA

Research payments

$404,569

73 payments

Through program year 2022, $404,569 in research payments was reported against A Phase 2,Open-Label, Single-Arm Study to Evaluate the Efficacy and SA, across 73 payments, paid by GlaxoSmithKline, LLC..

Paid by
GlaxoSmithKline, LLC.
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2022 Research $11,661 3
2021 Research $392,908 70

Breakdown

Who paid Research payments · program years 2021–2022
  1. GlaxoSmithKline, LLC. $404,569 73 payments
Who received the money Research payments · program years 2021–2022
  1. UC Irvine Medical Center Organisation paid for research $89,198 3 payments
  2. Florida Hospital Cancer Institute Organisation paid for research $50,776 4 payments
  3. Hoag Memorial Hospital Presbyterian Organisation paid for research $40,151 4 payments
  4. Ohio State Univ Research Found Organisation paid for research $37,380 2 payments
  5. Community Hospital South Teaching hospital · IN $30,888 3 payments
  6. Dana-Farber Cancer Institute Teaching hospital · MA $22,594 6 payments
  7. Memorial Sloan-Ketttering Cancer Center Organisation paid for research $19,371 4 payments
  8. Rush Univ Medical Center-Chicago-United Organisation paid for research $18,384 2 payments
  9. University Of Miami Organisation paid for research $17,607 5 payments
  10. The West Clinic Organisation paid for research $13,104 6 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record